Amarin Corp Plc (AMRN)

[hypo]

Vascepa is a heart medication technology disruption.

As so many on this board have described in the past we are seeing a “new knowledge” paradigm shift which is consistent with a technology disruption. Vascepa is just moving into the lower bend of the adoption “S” curve.

And, its application breadth is yet to be fully understood.

The question is; what will the S curve exponent become over the next few years.

While this Tony Seba link is not related to new drugs it will give you a sense of Vascepa's disruptive capacity.

Cheers, Hypo